𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiation therapy of mesothelioma: the Heidelberg experience and future aspects

✍ Scribed by Zierhut, Dietmar; Gutwein, Sybille; Münter, Marc W; Woger, Herrmann; Debus, J

Book ID
119318968
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
495 KB
Volume
45
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surgical complications of intraoperative
Surgical complications of intraoperative radiation therapy: The radiation therapy oncology group experience
✍ R. Dirk Noyes; Steven M. Weiss; John M. Krall; William T. Sause; Jake R. Owens; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Intraoperative radiotherapy (IORT) is being used with increasing frequency in many institutions in the United States but little is known about the surgical complication rates. The Radiation Therapy Oncology Group initiated three prospective studies in IORT in 1986 and we report here the experience i

[Medical Radiology] Technical Basis of R
[Medical Radiology] Technical Basis of Radiation Therapy Volume 125 || Physics and Clinical Aspects of Brachytherapy
✍ Levitt, Seymour H.; Purdy, James A. 📂 Article 📅 2006 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 967 KB

The New Edition Of This Book Is Divided Into Two Sections. The First Covers Basic Concepts In Treatment Planning, Including Essential Physics, And Explains The Various Approaches To Radiation Therapy, Such As Intensity-modulated Radiation Therapy, Tomotherapy, And High And Low Dose Rate Brachytherap

Carcinoma of the nasopharynx. Eighteen y
Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy
✍ Richard T. Hoppe; Don R. Goffinet; Malcolm A. Bagshaw 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

From 1956 through 1973, 82 patients with carcinoma of the nasopharynx received high dose megavoltage radiation therapy a t Stanford University. The actuarial disease-free (NED) survival was 62% a t 5 years and 56% a t 10 years. The NED survivals a t 5 years for patients with T I , T2, and T3 lesion